STAT September 8, 2018
Joel C. White

When President Barack Obama signed the landmark 21st Century Cures Act into law in December 2016, he was surrounded by elated Republican and Democratic lawmakers. At the time, Obama said the measure would bring “to reality the possibility of new breakthroughs to some of the greatest health challenges of our time.”

Republican Sen. Lamar Alexander, who chairs the Senate’s Committee on Health, Education Labor, and Pensions, hailed the act as “a Christmas miracle … that will help virtually every American family.”

Their statements weren’t hyperbole. The bipartisan $6.3 billion medical innovation package was chock-full of policies to modernize the National Institutes of Health and the Food and Drug Administration, combat the nationwide opioid epidemic, advance Obama’s Precision Medicine Initiative, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Cures Act, Govt Agencies, Regulations
What Washington wants in Cures 2.0
How ONC Can Strengthen Its HTI-1 Rule To Ensure Transparency, Fairness, And Equity In AI
Providers Take Note: The Common Agreement Version 2.0 Released
Advancing Nationwide, Trusted Health Information Networks
Cures Act tied to quicker release, access of imaging reports

Share This Article